Breaks Categories: News

MondayAug 18, 2025 10:55 am

NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) to Present at Emerging Growth Conference on August 20

Nutriband (NASDAQ: NTRB) announced it will participate in the Emerging Growth Conference on August 20, 2025. Chairman Serguei Melnik will deliver a live, interactive presentation and may open the floor for real-time questions from shareholders and the investment community. To view the full article, visit https://nnw.fm/9hMAH About Nutriband Inc. We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse-deterrent fentanyl patch incorporating our AVERSA(TM) abuse-deterrent technology. AVERSA(TM) technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse…

Continue Reading

MondayAug 18, 2025 10:40 am

NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Reports Q2 2025 Results, Highlights Progress Across Lead Programs and Strategic Investment

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, reported financial results for the quarter ended June 30, 2025, and provided a corporate update. The Company highlighted progress in all three lead programs, including expanded FDA Fast Track designation for NRX-100 in treating suicidal depression, filing of multiple regulatory documents, and advancement of the NRX-101 NDA. A strategic investor group led by B Group Capital has committed capital through a purchase of restricted common stock with a one-year lockup and no dilutive mechanisms. The capital is expected to support the Company through key regulatory milestones and help scale HOPE Therapeutics and…

Continue Reading

MondayAug 18, 2025 9:24 am

NetworkNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Awarded FDA Orphan Drug Designation for Dusquetide in Behçet’s Disease

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases, announced the U.S. FDA has granted orphan drug designation to dusquetide, the active ingredient in SGX945, for treatment of Behçet's Disease. The designation follows a review of recent Phase 2a clinical results demonstrating biological efficacy and safety in patients. To view the full press release, visit https://nnw.fm/ZvjnC About Soligenix Inc. Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Our Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte(TM) (SGX301 or…

Continue Reading

MondayAug 18, 2025 9:10 am

NetworkNewsBreaks – Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Completes Summer Exploration at Gochager Lake Despite Wildfire Disruption

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) has completed its summer field exploration program at the Gochager Lake Project. Crews collected 2,926 B-horizon soil samples across 3,183 planned sites and gathered 337 chip and grab rock samples from outcrops. All rock samples were analyzed on-site via pXRF for nickel, copper, cobalt, sulphur, and mafic-ultramafic pathfinder elements. Several mineralized samples have been sent for multi-element assay and whole rock geochemistry. Though a lightning-caused wildfire forced early evacuation and cut the program short by three days, approximately 90% of the targeted soil sampling was achieved. To view the full press release, visit:…

Continue Reading

MondayAug 18, 2025 9:00 am

NetworkNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Prices $7 Million Public Offering of Common Stock and Pre-Funded Warrants

Vision Marine Technologies (NASDAQ: VMAR), a leader in high-voltage electric marine propulsion systems and multi-brand boat retail and service, has priced a public offering of 3.5 million shares of common stock (or pre-funded warrants in lieu) at $2.00 per share, aiming to raise $7 million in gross proceeds before expenses. The Company also granted underwriters a 45-day option to purchase up to 525,000 additional shares and/or pre-funded warrants to cover over-allotments. The offering is expected to close on August 18, 2025, pending customary conditions. To view the full press release, visit https://nnw.fm/LKLTK About Vision Marine Technologies Inc. Vision Marine Technologies…

Continue Reading

FridayAug 15, 2025 3:54 pm

NetworkNewsBreaks – Comstock Inc. (NYSE: LODE) Prices $30 Million Public Offering to Fund Solar Panel Recycling Expansion

Comstock (NYSE: LODE) has priced its underwritten public offering of 13,333,334 shares at $2.25 per share, expecting gross proceeds of approximately $30 million before expenses. The Company plans to use the funds to fully finance commercialization of its first industry-scale solar panel recycling facility—capable of processing over 3 million panels annually—advance additional site selection, cover development costs and repay debt. CEO Corrado De Gasperis said the offering eliminates all outstanding debt and strengthens the Company’s cash position to accelerate growth in its recycling business. The offering, led by Titan Partners Group, is expected to close August 14, 2025, subject to…

Continue Reading

FridayAug 15, 2025 1:30 pm

NetworkNewsBreaks – Torr Metals Inc. (TSX.V: TMET) Identifies High-Grade Copper and Major Untested Porphyry Target at Kolos Project

Torr Metals Inc. (TSX.V: TMET) reported results from an induced polarization survey and rock grab sampling at the Bertha Zone within its 332 km2 Kolos Copper-Gold Project in British Columbia. Sampling from the historical Bertha pit returned up to 16.9% copper and 8.48 g/t silver along a 30 m strike, with mineralization extending more than 450 m between the Bertha and Bertha South showings where no drilling has been recorded. The high-grade copper sits on the margin of a newly defined greater than 900 m by greater than 500 m IP chargeability anomaly that remains open in multiple directions. All…

Continue Reading

FridayAug 15, 2025 11:08 am

NetworkNewsBreaks – Glidelogic Corp. (USOTC: GDLG) Launches Advanced AI-Powered ResearchMind Globally

Glidelogic (USOTC: GDLG) today announced the worldwide rollout of its upgraded ResearchMind platform after four months of invitation-only beta testing. Now available for $24.99 per full analysis report, the release integrates OpenAI GPT-5 and Anthropic Claude Opus 4.1 in its Pro version for academic partners, offering enhanced natural-language comprehension, domain adaptation and reasoning depth. Key improvements include extended reasoning time for deeper multi-stage analysis and expanded iteration cycles for more accurate, publication-ready proposals. “Our vision has always been to make AI an active collaborator in hypothesis formation—not just a productivity tool,” said CEO Fred (Yitian) Xue. “Leveraging compute as equity…

Continue Reading

FridayAug 15, 2025 10:35 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q2 2025 Results, Advances TPI 287 Toward Phase 2 GBM Trial

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company developing treatments for cancers in the brain and central nervous system, reported a Q2 2025 net loss of $2.4 million, slightly improved from $2.5 million in Q2 2024, driven by reduced Berubicin trial costs. R&D expenses rose to $1.2 million from $1.1 million on preparation for a TPI 287 trial, while G&A fell to $1.2 million from $1.4 million on lower legal, travel and stock-based compensation costs. The Company ended the quarter with $12.1 million in cash, sufficient to fund operations into the second half of 2026. CEO John Climaco said CNS is…

Continue Reading

FridayAug 15, 2025 10:33 am

NetworkNewsBreaks – WEBUY GLOBAL LTD (NASDAQ: WBUY) Closes $3 Million Offering of Shares and Pre-Funded Warrants 

WEBUY GLOBAL (NASDAQ: WBUY), a technology-driven company transforming community e-commerce and travel across Southeast Asia, has closed its offering of 721,918 Class A ordinary shares and pre-funded warrants to purchase up to 100,000 Class A ordinary shares to certain institutional investors. The transaction generated approximately $3 million in gross proceeds before placement agent fees and other expenses. D. Boral Capital LLC served as exclusive placement agent, with Ortoli Rosenstadt LLP advising the company and Hunter Taubman Fischer & Li LLC representing the placement agent. To view the full press release, visit https://nnw.fm/B8CfN About WEBUY GLOBAL LTD WEBUY GLOBAL LTD. is…

Continue Reading